Health & Life Sciences · All reports

Health & Life SciencesResearch paperSource analysis

Can an AI medical council give a safer second opinion?

A 300-case preprint found structured multi-stage reports scored better on management planning, but an automated judge, unusual published cases and unequal compute prevent any claim of clinical benefit.

By The Impact of AI Editorial Desk•Released 16 October 2026 at 13:00 BST•4 min full report · 1 min summary•1 source · view evidence

The short version

What happened
Eight model pipelines generated reports for 300 resolved NEJM cases: 110 for physician-based judge calibration and 190 for held-out evaluation.
Who it affects
Clinicians may benefit from a report that separates evidence, uncertainty and management, but they still need an independent way to verify every consequential recommendation.
What remains unproven
This is an unreviewed benchmark of published cases scored mainly by an automated judge. It tested neither clinician decisions nor patient outcomes and did not match compute between the compared workflows.

Keep in mind

This is an unreviewed benchmark of published cases scored mainly by an automated judge. It tested neither clinician decisions nor patient outcomes and did not match compute between the compared workflows.

Source analysis · 1 linked source. Primary analysed source date: 15 October 2026.

Read the full report · 4 min The evidence, methods, implications and limitations

The benchmark found better reports, not better care

A structured, multi-stage AI 'council' produced more highly rated clinical second-opinion reports than a single role-specific response in a new 300-case benchmark. Its clearest advantage was management planning. That finding could help researchers evaluate decision-support systems more realistically than asking only whether a model names the diagnosis. It does not show that an AI council makes clinicians more accurate or patients safer: no clinician used the reports in care, and no patient outcome was measured.

The unreviewed preprint, submitted on 15 October, used diagnostically resolved case records published in the New England Journal of Medicine between 2015 and 2023. Researchers assigned prompted clinical roles, generated independent opinions, then had the same model synthesise them through up to five review rounds. Eight model pipelines were tested under free-form and structured instructions. The correct-answer field was withheld from generation.[1]

How the 300 cases were divided and scored

A fixed 110-case set supplied physician reference ratings and calibration data for an automated LLM judge; the remaining 190 DOI-distinct cases formed the held-out evaluation. Six physicians rated outputs blind to model and format on a 0–3 rubric covering grounding, prioritisation, use of evidence, reasoning, differential diagnosis, final conclusion, management and safety. The calibrated judge then scored the large evaluation set: 6,080 response components and 54,720 criterion outcomes.

Across the held-out cases, structured final reports had higher overall mean scores in seven of eight pipelines. The pooled management score rose from 2.436 for free-form reports to 2.740 for structured reports. Final structured synthesis also scored above the pre-council primary-role output across five shared criteria. Model identity separated quality more strongly than format, and the strongest pipeline in the paper also consumed substantial resources: its mean tokens per case rose from about 65,200 free-form to 132,100 structured.[1]

The distinction that matters

What the benchmark compared

Each route began with the same published case, but the generation process differed.

Single role

One prompted specialty writes an opinion

Role-specific report

AI council

Several prompted roles are synthesised and reviewed

Final multidisciplinary report

The council route used more calls, context and tokens, so this is not an equal-compute comparison. Source: Bokov et al. (arXiv)

Why the council effect cannot be isolated

The council condition combined extra sampling, role prompts, aggregation, critique, revision and more context. There was no compute-matched control, so the study cannot say discussion itself caused the gain. Prompted specialties were simulated viewpoints rather than independently validated specialists and could repeat the same error. The cases also overrepresent rare, difficult diagnoses; titles and DOIs were supplied during synthesis, and public cases may have appeared in model training data.

The automated judge is another boundary. Physician calibration improved agreement on some criteria, but validation error remained high for the composite final-conclusion score. The paper reports no funding or competing-interests statement in the accessible version, while authors list academic, clinical, institute and commercial affiliations. A stronger next step would compare equal-compute pipelines prospectively, then test whether blinded clinicians using the reports make safer decisions. For now, the study supports a richer benchmark—not clinical deployment or patient self-diagnosis.[1]

Continue the story

Read next

All reports
Explore the full source and evidence record

What this means for people

  • Clinicians may benefit from a report that separates evidence, uncertainty and management, but they still need an independent way to verify every consequential recommendation.
  • Patients should not treat benchmark rankings as evidence that an AI second opinion is safe or effective for their own care.

Global context

The authors are mainly affiliated with Russian institutions, but the cases came from a US medical journal and the models are internationally available. Health systems would still need local validation, governance and prospective clinical evidence.

What the evidence does not yet show

  • This is an unreviewed benchmark of published cases scored mainly by an automated judge. It tested neither clinician decisions nor patient outcomes and did not match compute between the compared workflows.

What to watch next

  • Equal-compute replication, independent physician review and prospective trials measuring clinician decisions, workload and patient safety.

Living evidence record

Impact record IAI-1HSLRBT

Explore the full tracker

Evidence stage

Studied

Confidence

Supported

Reporting basis

Source analysis

Independent or research support

Not yet

Record status

Monitoring

Last checked

16 October 2026

Source trail

1 direct source across 1 source type.

People impact

Documented in this record.

Uncertainty

Limits and next checks are explicit.

Stages describe the evidence available—not whether a technology is good or bad. See the public method.

Single-source reporting disclosure

This record analyses one direct source. It can establish what Bokov et al. (arXiv) published or reported, but it is not independent corroboration of every performance claim or predicted outcome. The confidence label will change only when broader evidence is added.

Evidence trail

Sources used for this report

Links checked 16 October 2026

1Bokov et al. (arXiv)• Research paper• 15 October 2026• RussiaAI Consilium: a Benchmark of LLM Clinical Multidisciplinary Second OpinionsUnreviewed preprint submitted 15 October 2026. The authors list academic, clinical, institute and commercial affiliations. The paper does not include a funding or competing-interests statement in the accessible version.
Research question, topics and regions

Evaluation of LLM-generated multidisciplinary clinical second opinions

Topics: Clinical AI · Second opinions · AI evaluation · Patient safety · Multi-agent systems

Regions: Russia · Global

This report is labelled source analysis. We summarise and analyse source material in our own words; company statements remain attributed claims until independently supported. Translated summaries preserve the meaning of the original source and link back to it. Read our editorial standards.